Oral contraceptives, blood clotting and thrombosis.
D000991:Antithrombins / Q000032:analysis; D001777:Blood Coagulation / Q000187:drug effects*; D001779:Blood Coagulation Factors / Q000032:analysis; D001780:Blood Coagulation Tests / Q000379:methods; D001792:Blood Platelets; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004967:Estrogens / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D005342:Fibrinolysis; D006801:Humans; D011372:Progestins / Q000009:adverse effects; D013927:Thrombosis / Q000097:blood / Q000139:chemically induced*
D000991:Antithrombins; D001779:Blood Coagulation Factors; D003276:Contraceptives, Oral; D004967:Estrogens; D005338:Fibrin Fibrinogen Degradation Products; D011372:Progestins; D005340:Fibrinogen